Clinical Trials
2 trialsNCT04407247 2025-12-23
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT02638701 2025-07-08
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
University of California, San Francisco
Phase 1/2 Recruiting